POTENTIATION OF INTERFERON-ALPHA INVITRO ANTIVIRAL ACTIVITY BY INTERFERON-ALPHA IS NOT ABROGATED BY ANTIBODY TO INTERFERON-GAMMA

被引:2
|
作者
CAPOBIANCHI, MR
MATTANA, P
DIANZANI, F
机构
[1] Istituto di Virología, Université “La Sapienza”, Rome
来源
JOURNAL OF INTERFERON RESEARCH | 1993年 / 13卷 / 01期
关键词
D O I
10.1089/jir.1993.13.53
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The addition of minute amounts of recombinant interferon-gamma (IFN-gamma) to recombinant IFN-alpha2 significantly enhances its antiviral activity. Although this potentiating action of IFN-gamma is destroyed by treatment with acid, it is not significantly affected by treatment with antibodies to IFN-gamma, suggesting that IFN-gamma molecules can interact with cells to potentiate IFN-alpha activity, even in the presence of neutralizing antibodies. Implications of this phenomenon are multifaceted, including the possibility that other IFN activities can be altered synergistically by combinations of different IFN types, even in the presence of specific antibodies, which have been described to occur in vivo in several pathological conditions.
引用
收藏
页码:53 / 55
页数:3
相关论文
共 50 条
  • [1] BEHAVIORAL-EFFECTS OF MOUSE INTERFERON-ALPHA AND INTERFERON-GAMMA AND HUMAN INTERFERON-ALPHA IN MICE
    CRNIC, LS
    SEGALL, MA
    [J]. BRAIN RESEARCH, 1992, 590 (1-2) : 277 - 284
  • [2] CLINICAL-EXPERIENCES WITH INTERFERON-ALPHA AND INTERFERON-GAMMA
    STEINMANN, GG
    ROSENKAIMER, F
    LEITZ, G
    [J]. INTERNATIONAL REVIEW OF EXPERIMENTAL PATHOLOGY, 1993, 34 : 193 - 207
  • [3] INTERFERON-ALPHA AND INTERFERON-GAMMA EXPRESSION IN THE RAT TESTIS
    DEJUCQ, N
    DUGAST, I
    RUFFAULT, A
    VANDERMEIDE, PH
    JEGOU, B
    [J]. ENDOCRINOLOGY, 1995, 136 (11) : 4925 - 4931
  • [4] TRANSCRIPTION FACTORS INDUCED BY INTERFERON-ALPHA AND INTERFERON-GAMMA
    IMAM, AMA
    ACKRILL, AM
    DALE, TC
    KERR, IM
    STARK, GR
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (22) : 6573 - 6580
  • [5] DIFFERENTIAL-EFFECTS OF INTERFERON-GAMMA AND INTERFERON-ALPHA ON INVITRO MODEL OF ANGIOGENESIS
    MAHESHWARI, RK
    SRIKANTAN, V
    BHARTIYA, D
    KLEINMAN, HK
    GRANT, DS
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 146 (01) : 164 - 169
  • [6] TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA AND INTERFERON-GAMMA
    KLOKE, O
    MAY, D
    WANDL, U
    BECHER, R
    OPALKA, B
    BEER, U
    NIEDERLE, N
    [J]. BLUT, 1990, 61 (01): : 45 - 46
  • [7] INVIVO EFFECTS OF INTERFERON-ALPHA AND INTERFERON-GAMMA ON LIPOLYSIS AND KETOGENESIS
    MEMON, RA
    FEINGOLD, KR
    MOSER, AH
    DOERRLER, W
    GRUNFELD, C
    [J]. ENDOCRINOLOGY, 1992, 131 (04) : 1695 - 1702
  • [8] INTERFERON-ALPHA AND INTERFERON-GAMMA PRODUCTION IN CHILDREN WITH PRIMARY IMMUNODEFICIENCY
    TOVO, PA
    PUGLIESE, A
    SALOMONE, C
    BALBIANO, R
    ZOPPO, M
    NICOLA, P
    [J]. RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1987, 13 (04): : 389 - 394
  • [9] DIFFERING CELL RESPONSES TO INTERFERON-GAMMA AND TO INTERFERON-ALPHA AND INTERFERON-BETA
    WALLACH, D
    FELLOUS, M
    SCHLUSSEL, R
    REVEL, M
    [J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1982, 18 (06): : 21 - 21
  • [10] DEFINITION OF IMMUNOMODULATORY EFFECTS OF INTERFERON-ALPHA, INTERFERON-BETA, AND INTERFERON-GAMMA
    BORDEN, EC
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 179 - 179